Maitland Vs Mulligan Mobilization in Patients With Shoulder Pain

NCT ID: NCT07062679

Last Updated: 2025-09-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

46 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-15

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

* To find the effect of the Maitland Mobilization versus Mulligans Mobilization on the pain of the patient suffering from Shoulder pain.
* To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the functional status of the patient suffering from shoulder pain.
* To determine the effectiveness of Mulligans Mobilization versus Maitland Mobilization on the psychological health status of that patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Shoulder is the most movable joint in the human body. A group of four muscles and their tendons, called the rotator cuff, give the shoulder its wide range of motion Rotator cuff muscles Swelling, damage, or bone changes around the rotator cuff can cause shoulder pain. Shoulder pain is highly prevalent and among musculoskeletal disorders is the third most common reason for visiting a primary care physician

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Shoulder Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Maitland Mobilization Oscillatory Glides

Group Type EXPERIMENTAL

Maitland Oscillatory Glides/Mobilization

Intervention Type OTHER

Hot pack for 15 minutes Ultrasound for 5 minutes Maitland Mobilization Oscillatory Glides inferiorly during normal abduction. Glenohumeral caudal glide mobilization was given at the rate of 2-3 glides per second for 30 seconds for each glide, 5 sets were given.

(3 sessions per week for 4 weeks)

Group B

Mulligan Mobilization with Movement (MWM)

Group Type EXPERIMENTAL

Mulligan Mobilization with Movement (MWM)

Intervention Type OTHER

Hot pack for 15 minutes Ultrasound for 5 minutes Mobilization with Movement (MWM) Patient sitting with therapist posterolateral to him/her. Therapist places the Mulligan belt across the humeral head and to his waist. Patient movement (Flexion, extension, \& abduction respectively) combined with therapist-applied joint gliding (postero-lateral Glide) MWM will be performed.

3 sets of 10 reps per session (30 seconds rest between sets)

(3 sessions per week for 4 weeks)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Maitland Oscillatory Glides/Mobilization

Hot pack for 15 minutes Ultrasound for 5 minutes Maitland Mobilization Oscillatory Glides inferiorly during normal abduction. Glenohumeral caudal glide mobilization was given at the rate of 2-3 glides per second for 30 seconds for each glide, 5 sets were given.

(3 sessions per week for 4 weeks)

Intervention Type OTHER

Mulligan Mobilization with Movement (MWM)

Hot pack for 15 minutes Ultrasound for 5 minutes Mobilization with Movement (MWM) Patient sitting with therapist posterolateral to him/her. Therapist places the Mulligan belt across the humeral head and to his waist. Patient movement (Flexion, extension, \& abduction respectively) combined with therapist-applied joint gliding (postero-lateral Glide) MWM will be performed.

3 sets of 10 reps per session (30 seconds rest between sets)

(3 sessions per week for 4 weeks)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Shoulder pain from last 3 months to 1 year, Male and Female patients will be included \& Age 20 years to 60 years.

Exclusion Criteria

* Pain more than 1 year, Patients with certain shoulder structural deformities \& Patients with autoimmune disease.
Minimum Eligible Age

3 Months

Maximum Eligible Age

1 Year

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Riphah International University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ayesha Sadiq, MSPT (OMPT)

Role: PRINCIPAL_INVESTIGATOR

Riphah International University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saidu Group of Teaching Hospital Mingora Swat

Swāt, KPK, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ayesha Sadiq, MSPT (OMPT)

Role: CONTACT

03346257484

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ilyas Khan, MSPT

Role: primary

03459450602

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

REC-01011 Shah Alam Khan

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.